Results 91 to 100 of about 25,436 (310)

Vasopressin in Prevention of Lumbar Puncture Headache [PDF]

, 1968
Hamza Aziz, J. Pearce, Emily Miller
openalex   +1 more source

Annual Banned‐Substance Review 17th Edition—Analytical Approaches in Human Sports Drug Testing 2023/2024

Drug Testing and Analysis, EarlyView.
Scenarios of drug exposure and administration as well as detection assays for drugs and methods of sports doping published between 2023 and 2024 are critically reviewed and evaluated in context with the Prohibited List 2024 as established by the World Anti‐Doping Agency.
Mario  Thevis, Tiia  Kuuranne, Hans  Geyer   +2 more
wiley   +1 more source

Modification of the Antidiuretic Effect of Vasopressin by Acid and Alkaline Loads [PDF]

, 1965

openalex   +1 more source

The Impact of Triptorelin on Hormone Levels in Human and Its Metabolite Confirmation Using Liquid Chromatography–Ion Trap/Time‐of‐Flight Mass Spectrometry (LC/MS‐IT‐TOF) and Liquid Chromatography–Orbitrap (LC‐Orbitrap) for Doping Control Analysis

Drug Testing and Analysis, EarlyView.
Triptorelin (5–10) confirmation using LC/MS‐IT‐TOF and LC‐Orbitrap can be used as evidence of triptorelin abuse in doping control. ABSTRACT Triptorelin, a synthetic gonadotrophin‐releasing hormone (GnRH), is mainly used in the clinical treatment of prostate cancer.
Navaporn Saardpun, Cholsittapan Asawesna, Seksun Kaewklam, Premsant Sangkhum, Wisoot Kongchareonsombat, Thanit Kusamran, Darawan Pinthong   +6 more
wiley   +1 more source

Increased Plasma Arginine Vasopressin in Clinical Adrenocortical Insufficiency and Its Inhibition By Glucosteroids* [PDF]

, 1967
Abdul Barik Ahmed, Barbara Crutchfield George, Carlos Gonzalez-Auvert, Joseph F. Dingman   +3 more
openalex   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Effect of Adrenal steroid hormones on the response of the toad's urinary bladder to vasopressin [PDF]

, 1969
Jerome S. Handler, A S Preston, Jack Orloff   +2 more
openalex   +1 more source

Vasopressin and Memory Consolidation

, 1976
Publisher Summary The hypothalamic-neurohypophyseal system possibly makes use of (a) the general circulation for peripheral effects of posterior pituitary hormones; (b) the portal vessel system for the regulation of anterior pituitary function; and (c) the cerebrospinal fluid for CNS activities.
Gispen, W.H., Wied, D. de, Wimersma Greidanus, T.B. van, Bohus, B., Urban, I.   +4 more
openaire   +3 more sources

Kinetic Analysis of the Antidiuretic Action of Vasopressin and Adenosine-3′,5′-Monophosphate * [PDF]

, 1964
Isidore S. Edelman, Martin J. Petersen, Paul F. Gulyassy   +2 more
openalex   +1 more source

DanGer Shock‐like profile predicts the outcome in ST‐elevation myocardial infarction‐related cardiogenic shock

ESC Heart Failure, EarlyView.
Flow chart illustrates the analysed patients as well as main baseline characteristics and outcomes comparing DanGer Shock‐like versus DanGer Shock‐unlike patients. The composite safety endpoint comprises severe bleeding, limb ischaemia, haemolysis, device failure, and worsening of aortic regurgitation. CS indicates cardiogenic shock.
Norman Mangner, Johannes Mierke, Dominik Baron, Felix J. Woitek, Stephan Haussig, Thomas Nowack, Ephraim B. Winzer, Julia Fischer, Robert Höllriegel, Stefanie Jellinghaus, Axel Linke   +10 more
wiley   +1 more source